Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Beone Medicines Ltd (ONC)

Beone Medicines Ltd (ONC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Beone Medicines Ltd C/O BEONE MEDICINES I GMBH AESCHENGRABEN 27 21ST FLOOR BASEL V8 4051 CHE

https://beonemedicines.com Employees: 11,000 P: 41-61-685-1900

Sector:

Medical

Description:

BeOne Medicines is an oncology company which involved in discovering and developing treatments to cancer patients. BeOne Medicines, formerly known as BeiGene Ltd., is based in SAN CARLOS, Calif.

Key Statistics

Overview:

Market Capitalization, $K 37,086,928
Enterprise Value, $K 34,626,000
Shares Outstanding, K 109,663
Float, K 102,403
% Float 93.38%
Short Interest, K 1,302
Short Float 1.19%
Days to Cover 4.50
Short Volume Ratio 0.76
% of Insider Shareholders 6.62%
% of Institutional Shareholders 48.55%

Financials:

Annual Sales, $ 3,810 M
Annual Net Income, $ -644,790 K
Last Quarter Sales, $ 1,412 M
Last Quarter Net Income, $ 124,840 K
EBIT, $ 182,680 K
EBITDA, $ 354,440 K

Growth:

1-Year Return 64.70%
3-Year Return 26.94%
5-Year Return -9.70%
5-Year Revenue Growth 789.81%
5-Year Earnings Growth 61.27%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.09 on 11/06/25
Next Earnings Date 02/26/26
Earnings Per Share ttm 1.72
EPS Growth vs. Prev Qtr 29.76%
EPS Growth vs. Prev Year 194.78%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ONC Ratios

Ratio
Price/Earnings ttm 196.68
Price/Earnings forward 48.17
Price/Earnings to Growth N/A
Return-on-Equity % 5.52%
Return-on-Assets % 3.17%
Profit Margin % -16.92%
Debt/Equity 0.03
Price/Sales 7.57
Price/Cash Flow N/A
Price/Book 8.98
Book Value/Share 37.66
Interest Coverage -0.71
60-Month Beta 0.47
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar